Cluster headache patients show marked intensity dependence of cortical auditory evoked potentials during and outside the bout

Cephalalgia

Volumn 25, Issue 1, 2005, Pages 36-40

  Áfra, Judit ^a   Ertsey, C ^b   Bozsik, G ^b   Jelencsik, I ^b  

^a NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Cluster headache; IDAP; Serotonergic neurotransmission

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER HEADACHE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; EVOKED RESPONSE; FEMALE; HEADACHE; HUMAN; HYPOTHALAMUS; MALE; NEUROTRANSMISSION; PATHOGENESIS; SEROTONINERGIC SYSTEM;

ACOUSTIC STIMULATION; ADULT; ANALYSIS OF VARIANCE; AUDITORY CORTEX; CLUSTER HEADACHE; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 12444300222     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00801.x     Document Type: Article

References (39)

1. Ekbom K. Patterns of cluster headache with a note on the relations to angina pectoris and peptide ulcer. Acta Neurol Scand 1970; 46:225-37.
2. Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia 1978; 7:76-8.
3. Strittmater M, Hamann GF, Grauer M, Fischer C, Blaes F, Hoffman KH, et al. Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adreanl hormones in pathents with cluster headache. Neuroreport 1996; 7:1229-34.
4. Nelson RF. Testosterone levels in cluster and non-cluster migrainous patients. Headache 1978; 18:265-7.
5. Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during acitve cluster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50:207-13.
6. Leone M, Bussone G. A review of hormonal findings in cluster headache: evidence for hypothalamic involvement. Cephalalgia 1993; 13:309-17.
7. Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, et al. Double-blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30:411-7.
8. May A, Bahra A, Büchel C, Frackowiack RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275-8.
9. Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic gray matter in a patient wiht intractable cluster headache. New Engl J Med 2001; 345:1428-9.
10. Waeber C, Moskowitz M. 3H-sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiederbergs Arch Pharmacol 1995; 352:263-75.
11. Pascual J, del Arco C, Romón T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996; 16:317-22.
12. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain 2002; 125:976-84.
13. Ertsey C, Bozsik Gy, Áfra J, Jelencsik I. Changes in attack frequency and cluster headache type after prolonged sumatriptan treatment. Cephalalgia 2003; 23:759.
14. Zebenholzer K, Wober C, Vigl M, Wessely P. Eletriptan for the treatment of cluster headache? Cephalalgia 2002; 22 Suppl 1:27-8.
15. Loder E. Naratriptan in the prophylaxis of cluter headache. Headache 2002; 42:56-7.
16. D'Andrea G, Granella F, Alecci M, Manzoni GC. Serotonin metabolism in cluster headache. Cephalalgia 1998; 18:94-6.
17. Waldenlind E, Ros SB, Sääf J, Ekbom K, Wetterberg L. Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients. Cephalalgia 1985; 5:45-54.
18. Leone M, Attanasio A, Croci D, Libro G, Grazzi L, d'Amico D, et al. The m-chlorophenylpiperazine test in cluster headache: a study on central serotonergic activity. Cephalalgia 1997; 17:666-72.
19. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotoninergic neurotransmission: a new hypothesis. Biol Psychiatr 1993; 33:173-87.
20. Juckel G, Molnár M, Hegerl U, Csépe V, Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 1997; 41:1181-95.
21. Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potentials in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996; 46:1404-9.
22. Proietti Cecchini A, Áfra J, Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man. demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig®). Cephalalgia 1997; 17:849-54.
23. Sándor PS, Mascia A, Áfra J, Schoenen J. Differential effects of prophylactic anti-migraine medication on the intensity dependence of cortical auditory evoked potentials. Headache 2000; 40:30-5.
24. Áfra J, Proietti Cecchini A, Sándor PS, Schoenen J. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks. Clin Neurophysiol 2000; 111:1124-9.
25. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl 7:1-96.
26. Evers S, Bauer B, Suhr B, Husstedt IW, Grotemeyer Kh. Cognitive processing in primary headache: a study on event-related potentials. Neurology 1997; 48:108-13.
27. Evers S, Bauer B, Suhr B, Voss H, Frese A, Husstedt IW. Cognitive processing is involved in cluster headache but not in chronic paroxysmal hemicrania. Neurology 1999; 53:357-63.
28. Vingen JV, Pareja AJ, Stovner LJ. Quantitative evaluation of photophobia and phonophobia in cluster headache. Cephalalgia; 1998; 18:250-6.
29. Vanagaite J, Pareja JA, Storen O, White LR, Sand T, Stovner LJ. Light induced discomfort and pain in migraine. Cephalalgia 1997; 17:733-41.
30. Van den Pol AN, Tsujimoto KL. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: Immunocytochemical analysis of 25 neuronal antigens. Neuroscience 1985; 15:1049-86.
31. Glass JD, Dinardo LA. Dorsal raphe nuclear stimulation of SCN. serotonin release and circadian phase-resetting. Brain Res 2000; 859:224-32.
32. Starkey SJ, Skingle M. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea pig dorsal raphe nucleus. Neuropharmacology 1994; 33:393-402.
33. Silvestri R, Pace-Schott EF, Gersh T, Stickgold R, Salzman C, Hobson JA. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal. J Clin Psychiatry 2001; 62:642-52.
34. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Goldstein J, Brasseur M, et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 1987; 65:141-52.
35. Swaab DF, Fliers EA. A sexually dimorphic nucleus in the human brain. Science 1985; 228:1112-5.
36. Ter Horst GJ, Meijler WJ, Korf J, Kemper RHA. Trigeminal nociception-induced cerebral Fos expression in the conscious rat. Cephalalgia 2001; 21:963-75.
37. Hsieh JC, Hannerz J, Ingvar M. Right-lateralised central processing for pain of nitroglycerin-induced cluster headache. Pain 1996; 67:59-68.
38. Hardebo JE, Moskowitz MA. Synthesis of cluster headache pathophysiology. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The Headaches. New York: Raven Press, 1993:96-76.
39. Áfra J, Proietti Cecchini A, Schoenen J. Craniometric measures in cluster headache patients. Cephalalgia 1998; 18:143-5.